Aperio Group’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1.94M Sell
26,968
-1,068
-4% -$55.9K 0.01% 1247
2020
Q3
$1.28M Buy
28,036
+1,137
+4% +$47.5K ﹤0.01% 1326
2020
Q2
$1.22M Sell
26,899
-324
-1% -$14.5K ﹤0.01% 1330
2020
Q1
$1.05M Buy
27,223
+2,095
+8% +$96.4K ﹤0.01% 1287
2019
Q4
$1.16M Buy
25,128
+405
+2% +$17.5K ﹤0.01% 1360
2019
Q3
$1.01M Sell
24,723
-604
-2% -$26.1K ﹤0.01% 1393
2019
Q2
$1.22M Sell
25,327
-682
-3% -$35.9K 0.01% 1310
2019
Q1
$1.63M Buy
26,009
+1,216
+5% +$83.5K 0.01% 1125
2018
Q4
$1.48M Buy
24,793
+1,396
+6% +$83.8K 0.01% 1107
2018
Q3
$1.51M Buy
23,397
+440
+2% +$24.6K 0.01% 1181
2018
Q2
$1.03M Buy
22,957
+53
+0.2% +$2.11K ﹤0.01% 1373
2018
Q1
$711K Buy
22,904
+508
+2% +$16.7K ﹤0.01% 1519
2017
Q4
$670K Sell
22,396
-3,283
-13% -$95.1K ﹤0.01% 1556
2017
Q3
$847K Sell
25,679
-204
-0.8% -$7.07K ﹤0.01% 1365
2017
Q2
$866K Buy
+25,883
New +$772K 0.01% 1309

Other funds holding BEAT

Aperio Group's BEAT Position: Q4 2020 in Review

Aperio Group reduced its BioTelemetry, Inc. (BEAT) stake by 3.8% in Q4 2020, selling an estimated $55.9K and leaving 26,968 shares worth $1.94M. The position accounts for 0.01% of the portfolio, ranked #1247.

Aperio Group first reported a position in BEAT in Q2 2017 and has held it in 15 quarters since. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Aperio Group held 26,968 shares of BioTelemetry, Inc. worth $1.94M as of Q4 2020.
  • Aperio Group sold 1,068 BioTelemetry, Inc. shares in Q4 2020, an estimated $55.9K.
  • BioTelemetry, Inc. made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1247 holding.
  • Aperio Group first reported a position in BioTelemetry, Inc. in Q2 2017 and has held it in 15 quarters since.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.